Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

BACKGROUND: Little is known on factors predicting sunitinib toxicity. Recently, the condition of low muscle mass, named sarcopenia, was identified as a significant predictor of toxicity in metastatic renal cell cancer (mRCC) patients treated with sorafenib. We investigated whether sarcopenia could p...

Descripción completa

Detalles Bibliográficos
Autores principales: Huillard, O, Mir, O, Peyromaure, M, Tlemsani, C, Giroux, J, Boudou-Rouquette, P, Ropert, S, Delongchamps, N Barry, Zerbib, M, Goldwasser, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619075/
https://www.ncbi.nlm.nih.gov/pubmed/23462722
http://dx.doi.org/10.1038/bjc.2013.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619075/
https://www.ncbi.nlm.nih.gov/pubmed/23462722
http://dx.doi.org/10.1038/bjc.2013.58

Ejemplares similares